Evidence map›Paper›PMID 27759015›Full record

ArticleNature communications2016

A network property necessary for concentration robustness.

Jeanne M O Eloundou-Mbebi, Anika Küken, Nooshin Omranian, Sabrina Kleessen, Jost Neigenfind, Georg Basler, Zoran Nikoloski

Abstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeanne M O Eloundou-MbebiSystems Biology and Mathematical Modeling Group, Max Planck Institute of Molecular Plant Physiology, Am Muehlenber 1, 14476 Potsdam-Golm, Germany.
Anika KükenSystems Biology and Mathematical Modeling Group, Max Planck Institute of Molecular Plant Physiology, Am Muehlenber 1, 14476 Potsdam-Golm, Germany.
Nooshin OmranianSystems Biology and Mathematical Modeling Group, Max Planck Institute of Molecular Plant Physiology, Am Muehlenber 1, 14476 Potsdam-Golm, Germany.
Sabrina KleessenTargenomix, Am Muehlenberg 11, 14476 Potsdam-Golm, Germany.
Jost NeigenfindTargenomix, Am Muehlenberg 11, 14476 Potsdam-Golm, Germany.
Georg BaslerDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, California 94720, USA.
Zoran NikoloskiSystems Biology and Mathematical Modeling Group, Max Planck Institute of Molecular Plant Physiology, Am Muehlenber 1, 14476 Potsdam-Golm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintenance of functionality of complex cellular networks and entire organisms exposed to environmental perturbations often depends on concentration robustness of the underlying components. Yet, the reasons and consequences of concentration robustness in large-scale cellular networks remain largely unknown. Here, we derive a necessary condition for concentration robustness based only on the structure of networks endowed with mass action kinetics. The structural condition can be used to design targeted experiments to study concentration robustness. We show that metabolites satisfying the necessary condition are present in metabolic networks from diverse species, suggesting prevalence of this property across kingdoms of life. We also demonstrate that our predictions about concentration robustness of energy-related metabolites are in line with experimental evidence from Escherichia coli. The necessary condition is applicable to mass action biological systems of arbitrary size, and will enable understanding the implications of concentration robustness in genetic engineering strategies and medical applications.

Indexed as

Computer SimulationMetabolic Networks and PathwaysModels, BiologicalAdenosine TriphosphateEscherichia coliKineticsNADNADPOxidation-ReductionAdenosine TriphosphateNADNADP

Identifiers

PMID27759015
PMCPMC5075777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.